Shattuck Labs Inc. (STTK): Price and Financial Metrics


Shattuck Labs Inc. (STTK): $4.39

-0.04 (-0.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add STTK to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

STTK POWR Grades

  • STTK scores best on the Sentiment dimension, with a Sentiment rank ahead of 98.61% of US stocks.
  • STTK's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • STTK ranks lowest in Momentum; there it ranks in the 5th percentile.

STTK Stock Summary

  • Of note is the ratio of SHATTUCK LABS INC's sales and general administrative expense to its total operating expenses; merely 8.86% of US stocks have a lower such ratio.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.11 for SHATTUCK LABS INC; that's greater than it is for only 9.1% of US stocks.
  • Revenue growth over the past 12 months for SHATTUCK LABS INC comes in at 2,268.46%, a number that bests 99.58% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SHATTUCK LABS INC are OMGA, ARDS, FHTX, ABUS, and BOLT.
  • Visit STTK's SEC page to see the company's official filings. To visit the company's web site, go to www.shattucklabs.com.

STTK Valuation Summary

  • In comparison to the median Healthcare stock, STTK's price/sales ratio is 166.67% higher, now standing at 5.6.
  • STTK's EV/EBIT ratio has moved up 23.4 over the prior 28 months.

Below are key valuation metrics over time for STTK.

Stock Date P/S P/B P/E EV/EBIT
STTK 2023-01-30 5.6 0.8 -2.5 -1.9
STTK 2023-01-27 5.2 0.8 -2.3 -1.8
STTK 2023-01-26 5.0 0.8 -2.2 -1.7
STTK 2023-01-25 5.0 0.8 -2.2 -1.7
STTK 2023-01-24 4.5 0.7 -2.0 -1.5
STTK 2023-01-23 4.2 0.6 -1.8 -1.3

STTK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STTK has a Quality Grade of C, ranking ahead of 29.15% of graded US stocks.
  • STTK's asset turnover comes in at 0.006 -- ranking 405th of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows STTK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.006 1 -0.376
2020-12-31 0.050 1 -0.381

STTK Price Target

For more insight on analysts targets of STTK, see our STTK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $48.00 Average Broker Recommendation 1.5 (Moderate Buy)

STTK Stock Price Chart Interactive Chart >

Price chart for STTK

STTK Price/Volume Stats

Current price $4.39 52-week high $5.82
Prev. close $4.43 52-week low $1.85
Day low $4.29 Volume 2,360
Day high $4.43 Avg. volume 43,781
50-day MA $2.85 Dividend yield N/A
200-day MA $3.26 Market Cap 186.10M

Shattuck Labs Inc. (STTK) Company Bio


Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC) platform, a novel class of dual-function fusion proteins with applications in oncology and autoimmune disease. The company’s lead program, SL-279252 (PD1-Fc-OX40L), is being studied in a Phase I trial in collaboration with Takeda Pharmaceuticals. Its technology focuses on immuno-oncology research targeted towards patients with many cancer types, including melanoma, lung, and bladder, by endowing one molecule with multiple functions, with applicability across the entire spectrum of human disease that enables medical researchers to find a quick and painless detection of malignancy for later-stage cancer patients.


STTK Latest News Stream


Event/Time News Detail
Loading, please wait...

STTK Latest Social Stream


Loading social stream, please wait...

View Full STTK Social Stream

Latest STTK News From Around the Web

Below are the latest news stories about SHATTUCK LABS INC that investors may wish to consider to help them evaluate STTK as an investment opportunity.

We Think Shattuck Labs (NASDAQ:STTK) Needs To Drive Business Growth Carefully

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Yahoo | January 27, 2023

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023

AUSTIN, TX & DURHAM, NC, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today provided a corporate update and highlighted upcoming key milestones anticipated in 2023. “Throughout 2022, we focused on clinical execution to position ourselves for key clinical data rea

Yahoo | January 9, 2023

We Just Learned Something New About Shattuck Labs Inc. (NASDAQ: STTK) This Week With Its -4.56% Loss

During the last session, Shattuck Labs Inc. (NASDAQ:STTK)’s traded shares were 0.38 million. At the end of the trading day, the stock’s price was $2.30, reflecting an intraday loss of -4.17% or -$0.1. The 52-week high for the STTK share is $9.46, that puts it down -311.3 from that peak though still a striking 19.57% … We Just Learned Something New About Shattuck Labs Inc. (NASDAQ: STTK) This Week With Its -4.56% Loss Read More »

Marketing Sentinel | December 31, 2022

Multiple insiders bought Shattuck Labs, Inc. (NASDAQ:STTK) stock earlier this year, a positive sign for shareholders

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | December 13, 2022

Shattuck Labs, Inc. (STTK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Shattuck Labs, Inc. (STTK), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Yahoo | December 1, 2022

Read More 'STTK' Stories Here

STTK Price Returns

1-mo 51.38%
3-mo 111.06%
6-mo 18.33%
1-year -21.47%
3-year N/A
5-year N/A
YTD 90.87%
2022 -72.97%
2021 -83.76%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7965 seconds.